Sanofi (SNY): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Sanofi ( SNY) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.3%. By the end of trading, Sanofi rose $0.67 (1.3%) to $52.34 on light volume. Throughout the day, 856,071 shares of Sanofi exchanged hands as compared to its average daily volume of 1,783,800 shares. The stock ranged in a price between $51.79-$52.50 after having opened the day at $51.95 as compared to the previous trading day's close of $51.67. Other companies within the Health Care sector that increased today were: Retrophin ( RTRX), up 17.9%, SunLink Health Systems ( SSY), up 15.8%, Galectin Therapeutics ( GALT), up 12.9% and Evoke Pharma ( EVOK), up 11.3%.

Sanofi researches, develops, manufactures, and markets healthcare products. The company operates in three segments: Pharmaceuticals, Human Vaccines, and Animal Health. Sanofi has a market cap of $136.5 billion and is part of the drugs industry. Shares are down 3.6% year to date as of the close of trading on Wednesday. Currently there are 2 analysts that rate Sanofi a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Sanofi as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, ERBA Diagnostics ( ERB), down 7.7%, TearLab Corpoartion ( TEAR), down 7.0%, Rockwell Medical ( RMTI), down 6.7% and Tekmira Pharmaceuticals Corporation ( TKMR), down 6.7% , were all laggards within the health care sector with Humana ( HUM) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs